565 related articles for article (PubMed ID: 32739239)
1. Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease.
Borghi C; Agabiti-Rosei E; Johnson RJ; Kielstein JT; Lurbe E; Mancia G; Redon J; Stack AG; Tsioufis KP
Eur J Intern Med; 2020 Oct; 80():1-11. PubMed ID: 32739239
[TBL] [Abstract][Full Text] [Related]
2. Improving cardiovascular and renal outcomes in gout: what should we target?
Richette P; Perez-Ruiz F; Doherty M; Jansen TL; Nuki G; Pascual E; Punzi L; So AK; Bardin T
Nat Rev Rheumatol; 2014 Nov; 10(11):654-61. PubMed ID: 25136785
[TBL] [Abstract][Full Text] [Related]
3. [Comorbidity in gout and hyperuricemia: prevalence, causes, prospects of urate lowering therapy].
Eliseev MS; Novikova AM
Ter Arkh; 2019 May; 91(5):120-128. PubMed ID: 32598686
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular Disease in Gout and the Protective Effect of Treatments Including Urate-Lowering Therapy.
Gupta MK; Singh JA
Drugs; 2019 Apr; 79(5):531-541. PubMed ID: 30868398
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular and renal effects of hyperuricaemia and gout.
Viazzi F; Leoncini G; Pontremoli R
Reumatismo; 2012 Jan; 63(4):253-62. PubMed ID: 22303532
[TBL] [Abstract][Full Text] [Related]
6. Hypertension, its treatment, hyperuricaemia and gout.
Gibson TJ
Curr Opin Rheumatol; 2013 Mar; 25(2):217-22. PubMed ID: 23370375
[TBL] [Abstract][Full Text] [Related]
7. Hyperuricemia and Cardiovascular Disease.
Zhang S; Wang Y; Cheng J; Huangfu N; Zhao R; Xu Z; Zhang F; Zheng W; Zhang D
Curr Pharm Des; 2019; 25(6):700-709. PubMed ID: 30961478
[TBL] [Abstract][Full Text] [Related]
8. Uric Acid in Inflammation and the Pathogenesis of Atherosclerosis.
Kimura Y; Tsukui D; Kono H
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830282
[TBL] [Abstract][Full Text] [Related]
9. Gout, hyperuricemia, and the risk of cardiovascular disease: cause and effect?
Shah A; Keenan RT
Curr Rheumatol Rep; 2010 Apr; 12(2):118-24. PubMed ID: 20425020
[TBL] [Abstract][Full Text] [Related]
10. Gout and hyperuricaemia: modifiable cardiovascular risk factors?
Burnier M
Front Cardiovasc Med; 2023; 10():1190069. PubMed ID: 37304945
[TBL] [Abstract][Full Text] [Related]
11. The epidemiology of uric acid and fructose.
Rho YH; Zhu Y; Choi HK
Semin Nephrol; 2011 Sep; 31(5):410-9. PubMed ID: 22000647
[TBL] [Abstract][Full Text] [Related]
12. Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options.
Bardin T; Richette P
BMC Med; 2017 Jul; 15(1):123. PubMed ID: 28669352
[TBL] [Abstract][Full Text] [Related]
13. Overview of hyperuricaemia and gout.
Masseoud D; Rott K; Liu-Bryan R; Agudelo C
Curr Pharm Des; 2005; 11(32):4117-24. PubMed ID: 16375732
[TBL] [Abstract][Full Text] [Related]
14. Effect of canagliflozin on serum uric acid in patients with type 2 diabetes mellitus.
Davies MJ; Trujillo A; Vijapurkar U; Damaraju CV; Meininger G
Diabetes Obes Metab; 2015 Apr; 17(4):426-9. PubMed ID: 25600248
[TBL] [Abstract][Full Text] [Related]
15. Uric acid and cardiovascular disease: A clinical review.
Saito Y; Tanaka A; Node K; Kobayashi Y
J Cardiol; 2021 Jul; 78(1):51-57. PubMed ID: 33388217
[TBL] [Abstract][Full Text] [Related]
16. Gout and Metabolic Syndrome: a Tangled Web.
Thottam GE; Krasnokutsky S; Pillinger MH
Curr Rheumatol Rep; 2017 Aug; 19(10):60. PubMed ID: 28844079
[TBL] [Abstract][Full Text] [Related]
17. Recent insights into the pathogenesis of hyperuricaemia and gout.
Riches PL; Wright AF; Ralston SH
Hum Mol Genet; 2009 Oct; 18(R2):R177-84. PubMed ID: 19808794
[TBL] [Abstract][Full Text] [Related]
18. The role of uric acid in the pathogenesis of human cardiovascular disease.
Kanbay M; Segal M; Afsar B; Kang DH; Rodriguez-Iturbe B; Johnson RJ
Heart; 2013 Jun; 99(11):759-66. PubMed ID: 23343689
[TBL] [Abstract][Full Text] [Related]
19. [Gout as a systemic disease: systemic manifestations and comorbidities of hyperuricaemia].
Glasnović M
Reumatizam; 2012; 59(2):119-32. PubMed ID: 23745468
[TBL] [Abstract][Full Text] [Related]
20. CaseBook challenges: Managing gout, hyperuricemia and comorbidities -- dialogue with the experts.
Bakris GL; Doghramji PP; Keenan RT; Silber SH
Am J Med; 2014 Jan; 127(1):S1. PubMed ID: 24268074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]